Combination of 177Lu-TLX250 and Peposertib in Patients With Carbonic Anhydrase IX -Expressing Solid Tumors

Clinical trial NCT05868174 · RECRUITING

Trial details

NCT number: NCT05868174
Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor, Adult Advanced Solid Tumor Advanced Renal Cell Carcinoma

Start date: 2023-05-23
Primary completion: 2024-12-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.